NEW YORK (GenomeWeb) – Metamark Genetics today said that it has secured $10 million in financing to further expand its clinical testing products and services in the US and abroad. 

The new funding, the company added, will allow it to complete the development of other urologic assay products. Metamark also announced that Shawn Marcell has resigned as president and CEO of the firm to pursue other opportunities. He has been replaced by Kenneth Weg, a Metamark co-founder and current chairman of the board of directors. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.